Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert)
Home product recall 21-729. Announced by CPSC on Mar 18, 2021.
Watch and the shortlist are kept with a free account, on every device. Your watch list. CPSC’s own notice is on cpsc.gov.
The short answer
Announced by CPSC on Mar 18, 2021. Copied from CPSC on Oct 19, 2026.
Every line below is in CPSC’s own words, with its source beside it.
What’s wrong with it?
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
CPSC, Recalls API. Checked Oct 19, 2026. Updated daily.
What should you do?
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
CPSC, Recalls API. Checked Oct 19, 2026. Updated daily.
- What the company offers to fix a recalled product or vehicle: a repair, a replacement or a refund, as the recall notice says. For a vehicle, dealers make the safety repair free. Follow the notice’s own steps, or contact the company it names. Source: CPSC; NHTSA (49 U.S.C. 30120).: replace.
- How to reach the firm: Genentech at 800-334-0290 from 8 a.m. to 8 p.m. ET Monday through Friday or online at www.Evrysdi.com and click on the “leaking bottles safety information” banner on the homepage for more information.
Which ones are recalled?
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have “Evrysdi (risdiplam) for oral solution,” the dosage and “NDC 20242-175-07” on the front of the bottle labels.
About 14,000 units, as CPSC gives them.
Evrysdi™ (risdiplam).
CPSC, Recalls API. Checked Oct 19, 2026. Updated daily.
CPSC’s photos
CPSC shows 2 photos on its notice. Hearth Record doesn’t copy them; each opens on cpsc.gov.
Who made and sold it?
- Made by Genentech, a member, the Roche Group, of South San Francisco, Calif.
- Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
- Made in Switzerland, as the notice gives it.
CPSC, Recalls API. Checked Oct 19, 2026. Updated daily.
Was anyone hurt?
Genentech has received 26 reports of leaking bottles. No injuries have been reported.
CPSC, Recalls API. Checked Oct 19, 2026. Updated daily.
What the record doesn’t say
- The notice lists no UPCs, so check the model, the description and the photos.
- The notice lists no model numbers in a field of their own; its description may give them.
- How many have been returned or fixed isn’t in the notice.
Hearth Record wrote these lines.
Sources
-
U.S. Consumer Product Safety Commission, Recalls API.
Checked Oct 19, 2026. Updated daily. Public domain (U.S. Government work). CPSC asks to be credited, and that no endorsement be implied.
Recalls of kids’ and home products are from the U.S. Consumer Product Safety Commission (CPSC). CPSC does not endorse Hearth Record. Copied on Oct 19, 2026.